DanaherUS2358511028DHRDHR
Financials
Market Cap
$182.64B5Y beta
0.84EPS (TTM)
$5.898Free Float
661.04MP/E ratio (TTM)
41.81Revenue (TTM)
$23.74BEBITDA (TTM)
$7.44BFree Cashflow (TTM)
$4.76BPricing
Analyst Ratings
The price target is $270.50 and the stock is covered by 23 analysts.
Buy
17
Hold
5
Sell
1
Information
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.